Suppr超能文献

儿童严重颅锁骨发育不全和低磷酸酯酶症伴 RUNX2 羧基末端区域微缺失。

Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2.

机构信息

Faculty of Medicine, Cairo University, Egypt.

出版信息

Am J Med Genet A. 2010 Jan;152A(1):169-74. doi: 10.1002/ajmg.a.33146.

Abstract

Cleidocranial dysplasia (CCD) is a rare autosomal dominant skeletal dysplasia due to mutations causing haploinsufficiency of RUNX2, an osteoblast transcription factor specific for bone and cartilage. The classic form of CCD is characterized by delayed closure of the fontanels, hypoplastic or aplastic clavicles and dental anomalies. Clinical reports suggest that a subset of patients with CCD have skeletal changes which mimic hypophosphatasia (HPP). Mutations in RUNX2 are detected in approximately 65% of cases of CCD, and microdeletions occur in 13%. We present clinical and radiological features in a 6-year-old child with severe CCD manifested by absence of the clavicles marked calvarial hypomineralization, osteoporosis and progressive kyphoscoliosis. HPP features included Bowdler spurs, severe osteopenia, and low alkaline phosphatase. Following negative mutation analysis of RUNX2, comparative genomic hybridization (CGH) microarray was performed. The result revealed a microdeletion in RUNX2, disrupting the C-terminal part of the gene.

摘要

颅锁骨发育不全症(CCD)是一种罕见的常染色体显性遗传性骨骼发育不良症,由于 RUNX2 基因突变导致单倍剂量不足所致,RUNX2 是一种专门作用于骨骼和软骨的成骨细胞转录因子。经典型 CCD 的特征为囟门延迟闭合、锁骨发育不全或缺失以及牙齿异常。临床报告表明,CCD 的一部分患者骨骼变化类似于低磷酸酶血症(HPP)。约 65%的 CCD 病例可检测到 RUNX2 基因突变,13%的病例发生微缺失。我们介绍了一例 6 岁儿童的临床和影像学特征,该患儿患有严重的 CCD,表现为锁骨缺失、颅骨矿化不全、骨质疏松和进行性脊柱后凸。HPP 的特征包括 Bowdler 骨刺、严重的骨质疏松症和低碱性磷酸酶。在 RUNX2 突变分析呈阴性后,进行了比较基因组杂交(CGH)微阵列分析。结果显示 RUNX2 发生微缺失,破坏了基因的 C 末端部分。

相似文献

2
Genome sequencing identified a novel exonic microdeletion in the RUNX2 gene that causes cleidocranial dysplasia.
Clin Chim Acta. 2022 Mar 1;528:6-12. doi: 10.1016/j.cca.2022.01.010. Epub 2022 Jan 19.
3
A novel small deletion mutation in RUNX2 gene in one Chinese family with cleidocranial dysplasia.
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2490-5. eCollection 2014.
4
Severe cleidocranial dysplasia can mimic hypophosphatasia.
Eur J Pediatr. 2002 Nov;161(11):623-6. doi: 10.1007/s00431-002-0978-9. Epub 2002 Jun 28.
6
Cleidocranial dysplasia and RUNX2-clinical phenotype-genotype correlation.
Clin Genet. 2016 Nov;90(5):393-402. doi: 10.1111/cge.12812. Epub 2016 Jun 30.
7
Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia.
Eur J Pediatr. 2002 Nov;161(11):619-22. doi: 10.1007/s00431-002-0977-x. Epub 2002 Oct 9.
8
Familial cleidocranial dysplasia misdiagnosed as rickets over three generations.
Pediatr Int. 2015 Oct;57(5):1003-6. doi: 10.1111/ped.12692. Epub 2015 Aug 19.
9
A Case of Cleidocranial Dysplasia with a Novel Mutation and Growth Velocity Gain with Growth Hormone Treatment.
J Clin Res Pediatr Endocrinol. 2019 Sep 3;11(3):301-305. doi: 10.4274/jcrpe.galenos.2018.2018.0211. Epub 2018 Nov 23.
10
Classical cleidocranial dysplasia in an adult, due to a novel frameshift pathogenic variant in RUNX2.
BMJ Case Rep. 2016 May 13;2016:bcr2016215162. doi: 10.1136/bcr-2016-215162.

引用本文的文献

1
Mosaic Deletions of Known Genes Explain Skeletal Dysplasias With High and Low Bone Mass.
JBMR Plus. 2022 Jul 5;6(8):e10660. doi: 10.1002/jbm4.10660. eCollection 2022 Aug.
2
A Novel 90-kbp Deletion of Associated with Cleidocranial Dysplasia.
Genes (Basel). 2022 Jun 23;13(7):1128. doi: 10.3390/genes13071128.
4
Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
Adv Exp Med Biol. 2019;1148:279-322. doi: 10.1007/978-981-13-7709-9_13.
5
Cleidocranial dysplasia syndrome with epilepsy: a case report.
BMC Pediatr. 2019 Apr 8;19(1):97. doi: 10.1186/s12887-019-1472-0.
6
Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives.
Pediatr Radiol. 2019 Jan;49(1):3-22. doi: 10.1007/s00247-018-4239-0. Epub 2018 Oct 3.
8
Surgical Management and Evaluation of the Craniofacial Growth and Morphology in Cleidocranial Dysplasia.
J Craniofac Surg. 2018 Jun;29(4):959-965. doi: 10.1097/SCS.0000000000004334.
9
Classical cleidocranial dysplasia in an adult, due to a novel frameshift pathogenic variant in RUNX2.
BMJ Case Rep. 2016 May 13;2016:bcr2016215162. doi: 10.1136/bcr-2016-215162.
10
Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19.

本文引用的文献

1
Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia.
Genomic Med. 2008 Jan;2(1-2):45-9. doi: 10.1007/s11568-008-9024-y. Epub 2008 Aug 12.
2
Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.
Birth Defects Res A Clin Mol Teratol. 2006 Feb;76(2):78-85. doi: 10.1002/bdra.20231.
3
Cleidocranial dysplasia plus vascular anomalies with 6p21.2 microdeletion spanning RUNX2 and VEGF.
Am J Med Genet A. 2006 Feb 15;140(4):398-401. doi: 10.1002/ajmg.a.31061.
4
Dysregulation of chondrogenesis in human cleidocranial dysplasia.
Am J Hum Genet. 2005 Aug;77(2):305-12. doi: 10.1086/432261. Epub 2005 Jun 10.
6
Neonatal lethal osteochondrodysplasia with low serum levels of alkaline phosphatase and osteocalcin.
J Clin Endocrinol Metab. 2005 Feb;90(2):1233-40. doi: 10.1210/jc.2004-0251. Epub 2004 Nov 23.
7
Severe cleidocranial dysplasia can mimic hypophosphatasia.
Eur J Pediatr. 2002 Nov;161(11):623-6. doi: 10.1007/s00431-002-0978-9. Epub 2002 Jun 28.
8
Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia.
Eur J Pediatr. 2002 Nov;161(11):619-22. doi: 10.1007/s00431-002-0977-x. Epub 2002 Oct 9.
9
Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.
Hum Mutat. 2002 Mar;19(3):209-16. doi: 10.1002/humu.10043.
10
A natural history of cleidocranial dysplasia.
Am J Med Genet. 2001 Nov 15;104(1):1-6. doi: 10.1002/ajmg.10024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验